Mount Sinai researchers discovered that harmine, a beta cell regenerative drug, may transform alpha cells into beta cells, offering scalable diabetes treatment options for millions. Researchers and bioinformaticians at the Icahn School of Medicine at Mount Sinai have unveiled new insights into the mechanisms behind human beta cell regenerative drugs, offering a potential breakthrough for […]